American Biogenetic Sciences, Inc. - Statement of Stockholders' Equity (Deficiency) (USD $)	Common Stock, Share	Common Stock, Amount	Additional Paid-In Capital	Accumulated Deficit	Total Shareholders' Deficiency
Balance at Dec. 31, 2009	$ 1,088,740	$ 109	$ 46,191	$ (139,693)	$ (93,393)
Net loss year end				(62,792)	(62,792)
Balance at Dec. 31, 2010	1,088,740	109	46,191	(202,485)	(156,185)
Balance at Dec. 31, 2010
Net loss year end				(77,016)	(77,016)
Balance at Dec. 31, 2011	$ 1,088,740	$ 109	$ 46,191	$ (279,501)	$ (233,201)